Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M768Revenue $M11.4Net Margin (%)-122.2Z-Score6.7
Enterprise Value $M697EPS $-1.5Operating Margin %-79.7F-Score5
P/E(ttm))0Cash Flow Per Share $-0.9Pre-tax Margin (%)-122.4Higher ROA y-yN
Price/Book14.010-y EBITDA Growth Rate %0Quick Ratio2.5Cash flow > EarningsY
Price/Sales16.75-y EBITDA Growth Rate %0Current Ratio2.6Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-62.2Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)2ROE % (ttm)-129.3Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M51.3ROI % (ttm)-127.0Gross Margin Increase y-yY

Gurus Latest Trades with BDSI

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BDSIJulian Robertson 2013-12-31 Buy 0.92%$4.24 - $5.98
($5.13)
$ 14.98192%New holding, 510874 sh.510,874
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BDSI is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
BDSI Julian Robertson 2014-12-31510,87411.2
Premium Most recent portfolio changes are included for Premium Members only!


BDSI: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
De Paolantonio Ernest RobertCFO, Secretary and Treasurer 2015-02-25Sell3,050$14.443.74view
Sirgo Mark APresident and CEO 2015-02-25Sell94,000$14.255.12view
Finn Andrew LExecutive Vice President 2015-02-24Sell52,330$14.632.39view
ODONNELL FRANCIS E JRDirector 2015-02-23Sell55,000$14.443.74view
ODONNELL FRANCIS E JRDirector 2014-12-26Sell70,000$1224.83view
Sirgo Mark APresident and CEO 2014-12-15Buy2,500$12.2322.49view
SEARS SAMUEL P JRDirector 2014-12-10Sell7,853$15.03-0.33view
STONE WILLIAM BDirector 2014-11-12Sell14,000$16.11-7.01view
Sirgo Mark APresident and CEO 2014-09-04Buy2,000$15.04-0.4view
Feinberg Barry IDirector 2014-09-04Buy1,000$15.18-1.32view

Press Releases about BDSI :

    Quarterly/Annual Reports about BDSI:

    News about BDSI:

    Articles On GuruFocus.com
    Weekly CEO Sells Highlight: Vringo Inc, Medivation Inc, BioDelivery Sciences International Inc and H Feb 02 2014 
    comment on BDSI Mar 02 2013 
    comment on BDSI Jan 03 2013 
    comment on BDSI Jan 01 2013 
    comment on BDSI Nov 13 2012 
    Weekly CFO Sells Highlight: BDSI, LNKD, VRSK, ABMD, AGX Jul 17 2012 
    BioDelivery Sciences International Inc. Reports Operating Results (10-K/A) Nov 19 2010 
    BioDelivery Sciences International Inc. Reports Operating Results (10-Q) Aug 09 2010 
    BioDelivery Sciences International Inc. Reports Operating Results (10-Q) Aug 09 2010 
    BioDelivery Sciences International Inc. (BDSI) CEO Mark A Sirgo buys 4,022 Shares Jun 10 2010 

    More From Other Websites
    BioDelivery Sciences to Present at the 27th Annual ROTH Conference Mar 03 2015
    BioDelivery Sciences to Receive $10 Million Milestone Payment from Endo Pharmaceuticals Inc. in... Mar 03 2015
    BioDelivery Sciences to Present at the 27th Annual ROTH Conference Mar 03 2015
    Endo Pharmaceuticals and BioDelivery Sciences Announce Acceptance of NDA for BELBUCA™... Mar 02 2015
    BIODELIVERY SCIENCES INTERNATIONAL INC Files SEC form 8-K, Other Events, Financial Statements and... Feb 23 2015
    How Raleigh's BioDelivery will use $10M it got from partner on pain drug Feb 23 2015
    BioDelivery Sciences to Receive $10 Million Milestone Payment from Endo Pharmaceuticals Inc. in... Feb 23 2015
    Endo Pharmaceuticals and BioDelivery Sciences Announce Acceptance of NDA for BELBUCA™... Feb 23 2015
    Endo Pharmaceuticals and BioDelivery Sciences Announce Acceptance of NDA for BELBUCA™... Feb 23 2015
    BioDelivery Sciences to Present at the 2015 RBC Capital Markets Healthcare Conference Feb 18 2015
    BioDelivery Sciences to Present at the 2015 RBC Capital Markets Healthcare Conference Feb 18 2015
    BioDelivery Signs Agreement with Meda for Onsolis - Analyst Blog Jan 29 2015
    BIODELIVERY SCIENCES INTERNATIONAL INC Files SEC form 8-K, Entry into a Material Definitive... Jan 28 2015
    Podcast: Why the biotech boom is still in the 1st inning Jan 28 2015
    Raleigh drug co. to relaunch cancer pain medication; shares bounce Jan 27 2015
    BioDelivery Sciences Acquires North American Marketing Authorizations for ONSOLIS from Meda Jan 27 2015
    BioDelivery Sciences Acquires North American Marketing Authorizations for ONSOLIS from Meda Jan 27 2015
    BioDelivery Sciences International (BDSI) in Focus: Stock Up 5% - Tale of the Tape Jan 19 2015
    ENDO PHARMACEUTICALS AND BIODELIVERY SCIENCES ANNOUNCE NDA SUBMISSION FOR BUPRENORPHINE HCl BUCCAL... Dec 30 2014
    BIODELIVERY SCIENCES INTERNATIONAL INC Files SEC form 8-K, Other Events, Financial Statements and... Dec 24 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK